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ABSTRACT 
Inhibition of Synaptosomal Biogenic Amine Transport 
by a Diverse Group of Neurotoxic Chemicals 
by 
William M. Bracken, Master of Science 
Utah State University, 1980 
Major Professor: Dr. Raghubir P. Sharma 
Department: Toxicology 
ix 
Synaptosomal membrane functions were monitored, a f ter in vitro 
exposure to select environtr)ental pollutants, in synaptosomal prepara-
tions originationg from rat cerebral cortices. The uptake of NE 
and SHT into the synaptosomes was monitored as was the ~-dependent 
phosphatase activity of the membrane. CH3HgC1, Hg(N03 ) 2 , CdC12 , 
diisopropy1f1uorophosphate (DFP), paraoxon, acry1amide and Kepone 
were the test chemicals whose effects were studied. 
CH3HgC1, Hg(N03) 2 and Kepone had t he greatest inhib itory effects 
on NE and SHT uptake . The concentrations producing 50 percent 
inhibition (Ic50 ) were 1.4 x 10-
4
, 4 . 0 x 10 - 4 , and 9 . 4 x 10- S M, 
respective l y , for NE uptake while the rc50 •s for SHT uptake were 
1. 9 x 10- 4 , 6. 0 x 10-4 , and 3. 3 x 10-4 H, respectively . Maximal 
inhibition was 60- 100 percent at 10-3 M while the effective 
concentration range was between 10-4-10- 3 M. The remaining test 
compounds produced no significant inhibition at concentrations up 
- 3 to 10 M. 
X 
K+-dependent phosphatase was strongly inhibited by CH3HgCl, 
Hg(N03) 2 , CdC1 2 , and Kepone with rc50 •s of 1.5 x 10-
6
, 0.032 x 10~ 6 , 
1.5 x 10-6 , and 13.0 x 10- 6 M, respectively . The effective inhibitory 
concentrations for these chemicals ranged from 10-7-10- 3 M and 
suggested a specific high affinity inhibition. DFP, paraoxon and 
acrylamide did not produce a significant inhibition at concentrations 
- 5 -3 between 10 -10 M. 
A correlation of the phospha t ase and monoamine uptake inhibitions, 
in search of a cause- effect relationship, was not suggested from the 
data. However, the l ow affinity inhibition (rc50 greater than 10-
5 M) 
of the NE and SHT uptake by CH3HgCl, Hg(N03 ) 2 and Kepone, along with 
t he general shape of the dose-response c urve is suggestive of an all -
or- none inhibition. The apparent high affinity inhibition (rc50 less 
than 10-5 M) of the phosphatase demonstrates the specific influences 
these compounds can have on enzymatic processes. Such enzymatic 
inhibition could be of critical importance if these neuro toxicants 
were able to penetrate the synap t osomal or even neuronal membrane 
and gain access to the metabolic and synthetic machinery. 
( 107 pages) 
INTRODUCTION 
Federal regulations are restricting usage of many chemicals and 
preventing the use of others because of positive toxicological results 
in test systems . The manifestations of toxic effects assume various 
forms: cancer, neurotoxicity, metabolic poisoning, hepatic disease, 
etc. In recent years the neurotoxic potential of chemicals has 
become an increasing concern to health officials and federal agencies 
regulating their use . Mass poisonings by hexachlorobenzene, mercury, 
and tri-ortho-tolyl phosphate have resulted in victims with 
pathological and behavioral manifestations of neurological dys-
function (Allen et al., 1979; Harada, 1978; Smith et al . , 1930). 
Widespread usage of neurotoxic pesticides has increased the exposure 
and risk of both the occupational worker and the general public . 
With thousands of chemicals now in use and the continual development 
of new ones, an examination of the pathological , biochemical and 
physiological effects of chemicals is important for both the assess-
ment of their need for regulation and elucidation of their mechanism 
of action. 
As will be detailed in a subsequent chapter, several neurotoxic 
chemicals have been shown to alter neurotransmitter concentrations 
and metabolism in brain tissue. Although this relationship is 
promising for the development of a definitive hypothesis for the 
cause of their neurotoxicity, several problems associated with the 
tissue preparation must be overcome before a complete mechanism can 
2 
be presented. Studies of this nature have been performed in either 
brain slices or brain homogenates making it difficult to identify 
specific t ypes of target cells . In addition tissue homogenates mask 
the contribution of ionic gradients or intact plasma membranes in the 
expression of the toxicity . Disruption of the cellular compartmen-
talization in these preparations may also indirectly contribute to 
the observed changes by bringing together cellular constituents, 
not normally associat ed with the neurotransmitters, tha t i n some 
non- specific manner may influence their metabolism. To overcome these 
deficiencies synapt osomal preparations can be used to monitor both 
metabolism and transport processes in intact structural units that 
are more indicative of the in situ conditions. 
Synaptosomes are synaptic terminals which have been sheared , 
duFing fractionation, from their axonal connections and surrounding 
I 
glial cells. After separation from the axon the terminal capsule 
reseals forming the intact structural unit (Jones, 1975). Often the 
inter- synaptic clef t and post-synaptic process are isolated as a 
portion of this unit. Utilization of synaptosomes as a model for the 
investigation of neurotransmission has several advantages. First, 
the integrity of the membrane and demonstration of its functional 
capacity is comparable to the in situ condition at the synapse . 
Secondly, the characterization of their metabolic activity indicates 
that all enzymes and co- factors are present as would be seen in vivo. 
Thirdly, the studies showing t he viability of synaptosomes for 
several hours after removal from the brain allows for the time related 
studies. A final advantage would be the characterization of synaptic 
activity away from the diluting factors seen with tissue homogenates. 
3 
Behavioral change is seldom util iz ed as a tool for t oxicity 
t esting unless gr oss changes are apparent . Neurotoxicity is usually 
measured in terms of morphological damage rather than less apparent 
biochemical lesions. Subtle biochemical changes, although not as 
lethal initially, may ultimately be just as damaging. As will be 
outlined in the following chapter behavioral modification has been 
associa t ed with altera t ions of the biogenic amine neurotransmitter 
levels. Subtle changes in these levels may not produce acute modi-
fication but if t hese changes persist ove r long periods of time it 
is not known what behavioral alterations, if any, may take place . 
Detrimental changes in aggres sive and r eproductive behavior, as an 
example, would possibly have serious consequences for the survival of 
a species. 
Investigation of the effects neur otoxic chemicals may have on 
neuro-transmitter function would yield valuable information concerning 
possible mechanisms of action. Parameters of concern would include 
metabolism, synthesis, release and up take of t he transmitters. 
Alteration in any of these processes could initiate a potentially 
hazardous result and can easily be monitored in a synaptosomal model 
system. 
The present study is concerned with the examination of the 
effects various neurotoxic environmental pollutants, from several 
classifications, have on synap t ic inactivation of norepinephrine 
and serotonin . An initial characterization of the synaptosomal 
preparations to determine optimum assay conditions along with a 
comparison of the obtained Km and Vmax values fo r the uptake processes 
4 
with known literature values was performed to assess the suitability 
of the synaptosomal preparations for the study. These synaptosomes, 
obtained from the cerebral cortex of the male rats were then used 
to determine if in vitro exposure to the test chemicals (CH3HgCl, 
Hg(N03) 2 , CdC12 , diisopropylfluorophosphate (DFP), paraoxon, 
acrylamide and Kepone) modified the kinetics of the carrier-mediated 
memb rane transport of the neurotransmitters. K+-dependent phos-
phatase activity was monitored in the synaptosomal membrane to 
determine if effects the test chemicals have on t he neurotransmitter 
uptake is specific in nature or a result of a more indirect membrane 
effect. 
Since t he mechanism of the toxici ty of the neurotoxic agents 
under study is in all probability not dependent on synaptic transport 
phenomena, the present investigation will elucidate the potential 
these t oxican ts have for synaptic interactions and possible behavioral 
modification via an interruption of normal information flow in the 
cen tral nervous system. 
LITERATURE REVIEW 
Pharmacological Modification of Central 
Nervous System Functions 
5 
The brain, as an organ, is an integrated composite of many 
distinct structures whose overall function is dependent on an 
accurate, reproducible but flexible information flow between 
individual components. The limbic system is an example of this 
interdependency that is commonly seen in the central nervous system 
(CNS) . The total system is composed of units predominately in the 
brain stem and midbrain sections (hypothalamus, basal ganglia, 
amygdala, hippocampus and thalamus) joined by phylogenetically older 
cerebral cortical areas (medial and ventral portions) known as the 
limbic cortex . Together these units are involved with special types 
of behavior associated with emotions, subconscious motor and sensory 
drives and the intrinsic feelings of pain and pleasure (Guyton, 1976). 
Signals originating from parts of the limbic system other than the 
hypo t halamus are funneled through the hypo t halamus and give rise to 
various vegetative or behavioral effects that are known to occur 
after stimulation of the hypothalamus. At the same time the 
reticular activating system receives limbic signals to regulate 
the degree of wakefulness, alertness and attention while the non-
limbic portion of the cerebral cortex receives behavioral signals 
directly from t he limbic structures affecting cortical analytical 
function, sensory function, and at times even its motor function . 
6 
To facilitate information transfer to the appropriate areas of 
the brain the synaptic junction or synapse regulates the passage of 
the signals from one neuron to the next. Two key functions imparted 
by this regulatory process are directionality and selectivity . 
Directionality provides an organized pattern for receiving and 
transmitting signals while selectivity adds a two dimensional process 
that expands the range of interpretation for each signal. Without 
an inherent order in the signal processing inefficiency in information 
flow would reduce the effectiveness of the integrated functions of 
the nervous system. The selective nature of the synapse occurs in 
the positive and negative feedback processes which filter out 
unnecessary stimuli while passing on other stimuli t hat is needed for 
normal nervous function. 
With the central role the synapse has in the processing of 
signals within the CNS it becomes a primary target for pharmacological 
manipulation . Koelle (1975) discussed the ability of selected drug 
types to elicit peripheral as well as central nervous system 
responses during drug therapy. Morphine and other opiates that produce 
analgesia, drowsiness, changes in mood and mental clouding when 
administered in humans, are primarily affecting higher levels of the 
CNS. Smith and Sheldon (1973) mentioned that morphine increases the 
release, synthesis, and turnover of catecholamines and more recently 
it has been found to compete for neuroactive peptide receptor sites 
(Hughes, 1978). Anti - psychotic drugs such as chlorpromazine 
(phenothiazine type) and haloperidol (butyrophenone type) similarly 
decrease depression and the psychotic states in men t ally disturbed 
patients. As yet unexplained changes are produced in normal patients 
given these drugs; a decrease in motor activity and minimal responsive-
ness to stimuli are known to occur while inhibition of performance 
on complex intellectual tests are suggested. Biochemical monitoring 
of synaptic activity showed that these anti-psychotic drugs inhibit 
inactivation of nonrepinephrine and serotonin, by preventing re-uptake 
into the synaptic terminals, producing a gradual decrease in monamine 
concentration (Brucke et al., 1969). Along with uptake inhibition 
chlorpromazine, at low concentrations, enhances membrane permeability 
in some systems suggesting that direct membrane effects may alter 
the Na+ gradient required for membrane transport of the biogenic 
amines (Maoi et al., 1979). Tricyclic anti-depressants (i.e . , 
imipramine and desipramine) which produce anti-psychotic responses 
similar to the phenothiazines and butyrophenones, are specific, 
highly potent inhibitors of serotonin and norepinephrine re-uptake 
(Wedley et al., 1978; Fuller and Wong, 1977). 
Reserpine prevents the storage of biogenic amines in synaptic 
vesicles and subsequently causes a virtual depletion in monoamine 
concentration (Koelle, 1975) . Monamine depletion occurs through an 
increased monamine oxidase activity since the intracellular concentra-
tions of these neurotransmitters are initially increased on drug 
exposure. With time the amount of transmitter released into the 
synaptic cleft after membrane depolarization is decreased and this 
ultimately affects the degree of post-synaptic activation. Reserpine 
exposure in humans produces a state of indifference to environmental 
stimuli and a tendency towards sleep. 
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Benzodiazapines and related diazapams are t he most commonly 
prescribed anti-anxiety drugs in use t oday. Animal behavior s tudies 
have indicated that a lowering of ca techolamine turnover is 
responsible fo r the depressant action of t hese drugs while anti-
anxie t y responses may be attributed to decreasing t he serotonin 
turnover (Stein et al., 1975) . Rastogi et al. (1979) determined that 
ch ronic administration of diazepam to rats produced increased syna-
potosomal serotonin concentrations that were double the concentration 
found in acute exposure. Chronic exposure inc reased as well the 
uptake a nd the rate of synthesi s of sero tonin. From their studies 
Rastogi et al. (1979) conc luded that diazepam exerts its central 
effects on mood and behavior by impairing the release of serotonin, 
and to a lesser extent catecholamines. 
From the drug literature it is understood that modulation of 
synap t ic function is a useful means for producing behavioral responses. 
In discussing these pharmacologically induced behavioral changes 
Koelle (1975) pointed out that modification of synaptic activity 
can be br ought about by us ing drugs that affect neurotransmitter 
synthes i s , metabolism and turnover as well as the membrane release 
and uptake mechanisms . Additional modification can occur by 
altering the synaptic membrane integrity, either increasing or 
decreasing its fluidity or plasticity or by using drugs that 
compe t e for post- synaptic membrane recepto rs t hus enhancing or 
inhibiting the membrane response. 
Norepinephrine and 5-Hydroxytryptamine (Serotonin)--
Localization and Removal from the Synaptic Cleft 
9 
In a general discussion of the catecholamines, norepinephrine 
(NE) and dopamine (DA), and the indolamine, 5-hydroxytryptamine 
(5-HT), Synder (1976) pointed out that these biogenic amines are the 
only putative neurotransmitters which have been localized in 
discrete nerve tracts of t he brain and whose relationship with 
specific animal or human behavior has been worked out. Stereotaxic 
mapping, utilizing a histochemical fluorescence method, reveals that 
NE and 5-HT, although widely distribut ed in low concentrations 
throughout the brain, congregat~ in ce ll bodies to t he mutual 
exclusion of the other (Ungersted t, 1971). NE cell bodies are 
extremely prominent in the locus coeruleus and give off both ascending 
and descending bundles which reach all levels of the brain and spinal 
cord. Cell bodies containing 5-HT concentrate in the raphe nuclei 
of the lower midbrain and upper pons. The sertoninergic axons 
eminating from these nuclei ascend primarily into the forebrain from 
which they then disperse to all areas of the brain. 
Termination of the effects of NE and 5- HT , after release into 
the synpatic cleft, occurs through a membrane transport phenomena 
that returns these neurotransmitters back into the presynaptic 
terminal. This process, which is energy and temperature dependent, 
obeys Micahelis - Menten kinetics and is believed to be highly 
specific for only one type of monoamine in any one terminal 
(Iverson, 1971). Na+ and K+, at physiological concentrations, are 
required for op timum activity and it is believed that the divalent 
10 
++ ++ 
cations Mg and Ca as well have some function i n maintain ing this 
activity at peak levels (White , 1975) . 
Discovery of this re-uptake is c r edi ted to Axelrod and his 
co-workers (1965) , who found t hat radiolabelled, intravenously 
injected, NE accumulated in tissues with dense sympathetic innervation. 
Homogenization of this tissue and subsequent use of density gradients 
revealed the label to be localized in the synaptic vesicles. Later 
work by Iverson and his coworkers (1967) revealed that the granular 
storage process could be separated from the actual uptake into the 
nerve terminals by using the drug resperine which enhances the release 
of the monoamines from the storage vesicles but does not disrupt 
membrane transport into t he terminal . 
A carrier- mediat ed model for the transport of biogenic amines 
across pre- and post-synaptic membranes and into glial cells has 
been suggested by Hammerschlag and Roberts (1976). In this model 
the uptake process has an absolute Na+ requiremen t and operates at 
maximum velocity at physiologic Na+ concentrations. Binding sites 
for the transmitter exist in the synaptic membranes, are specific in 
nature, and have an affinity with a Km of less than 1.0 ~M for t he 
monoamines. These amines bind much more readily in environments 
with high Na+ concentrations (extracellular membrane surface) and 
much less readily in low sodium environments (intracellular membrane 
surface). As the transmitter is relased into t he synapse during 
neuronal activity, equilibration between receptor and transmitter 
occurs because of the high Na+ concentrations in the synapse . Under 
this condition the transmitter readily binds to the receptor and in 
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a process that is not yet understood but may depend upon various 
asymmetries on the two sides of the membrane, such as oxidation-
reduction potentials, degree of phosphorylation and concentrations 
of particular ions or metabolites, the transmitter is transported 
through t he membrane into the intracellular compartment. Since 
intracellular Na+ concentration is low the transmitter rapidly 
dissociates from the r eceptor and becomes available for mitochondrial 
metabolism. Thus it is suggested that the assymmetrical Na+ 
concentration sets up the conditions necessary for transport of 
these transmitters. Although metaboli cally generated ATP is not 
directly required for this process there is an overall energy require-
ment for the transport to occur. It is felt tha t the potential 
energy of the Na+ gradient is probably the major source of energy 
for the carrier-mediated transport. ATP is, of course, required for 
operation of the Na+ pump (Na+, K+-ATPase) that maint ains the Na+ 
gradient . 
§elected Aspects of Organophosphate 
Neurotoxicity 
Acute toxicity of o r ganophosphates is a product of t he specific 
inhibition of ace t ylcholinesterase with the resutling accentuation 
of cholinergic activity. Although this esterase inhibition is the 
most acute effect, other enzyme inhibitions are known that are 
unrelated to the cholinesterase inhibition. Jovic et al. (1971) 
treated rats with 3.2 mg/kg DFP (1.3 x LD50 ), after atropine pre-
treatment, and demonstrated a significant reduction in the succinate 
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dehydrogenase, aldolase and Na+, K+-ATPase activities in brain slices. 
Qualitatively similar effects were also detected in vitro. Although 
the study was performed utilizing a lethal dose of DFP it none the 
less implicated this compound and possibly other structurally related 
organophosphates as inhibitors of cellular metabolism. 
For sometime it has been known that organophosphates produce 
peripheral delayed neuropathies resulting in axo nal degeneration and 
paralysis of affected limbs (Smith et al. 1930). Initially the 
foci a t which the organophosphates initiated this response was though t 
to be the neuronal perikarya followed by retrograde axonal degener-
ation resulting frofu interference with somal metabolic functions 
(Cavanagh, 1964). Since then modern techniques have demonstrated 
this hypothesis to be inaccurate. Bouldin and Cavanagh (1979) have 
presented evidence that the initial leasion commencing axonal 
degeneration occurs within the axon itself. Utilizing a teased nerve 
fiber technique they were able to determine that the point of origin 
ofthe neuropathy was in the distal, but non- terminal, segment of 
the longest and largest nerve fibers. Subsequent to the initial 
lesion the axonal degeneration spread in a somatofugal direction to 
involve the entire distal axon . Prior to this degeneration fiber 
varicosities and demyelinated segments were identified. 
In support of Bouldin and Cavanagh's (1979) evidence for an 
initial axonal lesion preceeding the axonal degeneration is a study 
by Howland et al . (1980) . The authors used a technique that allowed 
them to produce a mononeuropathy involving only one hind limb. 
By injecting radiolabelled DFP (2 mg / kg) into the left femoral 
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artery of a cat and sectioning t he sciatic nerve in both the treateD 
and contralateral sides, as well as spinal gangalia and dorsal and 
ventral roots, one and twenty-four hours post treatment, they were 
able to determine that DFP was restricted to the injected leg with 
very little migration of label to the contralateral side or into the 
r oots or ganglia. The authors feel that if the perikarya were 
involved in the genesis of this mononeuropathy it would be manifested 
on both sides and significant levels of DFP would have been detected 
in the somal preparations. 
In a study of the functional capacity of motor nerve terminals 
during DFP induced neuropathies Lowndes and Baker (1978) detected 
a decrease in the ability of soleus alpha terminals to generate 
stimulus-bound repetition. This depressed activity reached a maximum 
21 days post exposure. Histologically the motor nerve t erminal 
underwent marked degenerative changes but it appeared not to effect 
the conduction velocity or single impulse transmission, both of which 
were normal. At this point the animal demonstrated a high-fast 
step gait in the neuropathic limbs while the primary spindle 
frequency of firing at various lengths of stretch was decreased. 
The above studies, for the most part, were concerned with the 
cholinergic parts of the nervous system. They provided evidence 
that DFP was capable of inducing degenerative changes in the nerve 
fibers after exposure to a concentration of DFP greater than t hat 
normally considered lethal. Little information is available on the 
affects produced after low level chronic exposure. Since DFP and 
other organophosphates are known to carry out membrane phosphorylation 
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(Johnson, 1969) and also since Jovic et al. (1971) reported the 
ability of DFP to inhibit CNS metabolic functions after in vivo 
treatment, it would be of interest to assess the membrane effects 
occurring within the CNS after organophosphate exposure. Of 
particular interest wo uld be the effects phosphorylation might have 
on synaptic transmission and other synaptic membrane function. 
Selected Aspects of Heavy 
Metal Neurotoxicity 
Pathological changes within the nervous system, biochemical, 
functional and morphological, are documented expressions of heavy 
meta l poisoning, of which lead and mercury have been the most 
intensely studied (Hrdina et al., 1976; Pentschew, 1965; Smith, 
1976) . Arsenic and cadmium exposure is also known to initiate 
neuropathology in experimental animals (Gabbiani et al., 1967; 
Hrdina et al., 1976; Krigman, 1978; Rastogi et al., 1977; Sato et 
al., 1978) but ~uch less is know about their mechanisms of action . 
In the studies mentioned, as well as others, it is generally 
accepted tha t as a group heavy metals are able to effect both the 
peripheral and central nervous systems. Some of these metals are 
capable of injuring both systems while others are specific for one 
or the other. The critical factor in determining the type of 
injury is t he solubility and distribution of a particular metal in 
the body. The type of injury produced is similar in both systems. 
Oehme (1978) felt that in general terms the toxicity of heavy 
metals is principally a consequence of their high affinity for 
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many ligands such as proteins and amino acids. Metal complexes are 
readily formed with sulfhydryl groups and to lesser degrees with 
amino, phosphate, carboxylate, imidazole and hydroxyl radicals of 
biologically significant compounds, often resulting in protein 
degeneration. With the high affinity many metals have for protein 
constituents and the significant role proteins have in membrane 
structure and function it is to be anticipated that membrane barriers 
might sustain considerable damage after heavy metal exposure. 
In a review of the toxic effects of mercury, Chang (1977) stated 
that the neuropathology is a consequence of membrane degeneration 
followed by metabolic dysfunction that leads to functional changes 
in the neurophysiology of neuron and axon. This scenario is supported 
by information showing subcellular accumulation of mercury occurring 
in membrane fractions when characterizing the subcellular distribution 
by ultracentrifugation (Yoshino et al., 1966a). More recently 
electron-microscopic histochemical methods (metal-sulfide coupling) 
were able to demonstrate visually the close associations of mercury 
with membranous structures and the increasing amounts detected in 
the matrix of the cytoplasm and axoplasm as the intoxication 
progressed (Chang and Hartman, 1972a). Surprisingly this study 
indicated that very little mercury penetrates through the nuclear 
membrane. 
It has been known for some time that mercury inhibits protein 
synthesis prior to development of neurologic symptoms while oxygen 
consumption, aerobic and anaerobic glycolysis and sulfhydryl enzyme 
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activities remain unchanged (Yoshino et al., 1966b). It subsequently 
was found that many enzyme activities were altered after mercury 
intoxication and the onset of neurologic symptoms. Succinic 
dehydrogenase , ATPase and alkaline phosphatese activities decreased 
indicating damage to mitochrondia, cell membranes and the blood-brain 
barrier by mercury. Paterson and Usher (1971) detected a decrease 
in the ATP/ADP and ATP/AMP ratios as well as inhibition of enz}~es 
towards the end of the glycolytic chain in mercury treated rats. 
Salvaterra et al. (1973) extended these metabolic studies and found 
changes in phosphocreatine and adenosine nucleotides as well as 
glycolytic intermediates. RNA synthesis is also altered after 
mercury intoxication but conflicting results have been obtained 
indicating that increased or decreased sys thesis may be dependent 
on the susceptibility of specific cell types (Brubaker et al., 1973; 
Chang and Hartman, 1972a,b). Somjen et al. (1973) reported that the 
intracellularly recorded spike potential of many sensory ganglion 
neurons of mercury poisoned rats was significantly prolonged, 
indicating a retardation in membrane repolatization. These au t hors 
also indicated that t he primary site of damage is the cell bodies of 
the sensory ganglion cells followed by axonal degenera tion and that 
the largest myelinated fibers were affected to a greater extent than 
the smaller fibers. 
Human sensitivity to cadmium induced neurotoxicity is so poorly 
documented that Kr igman (1978) stated that neurotoxicity is not a 
feature of cadmium poisoning in humans. However, Vo robj eva (1957) 
examined 160 facto r y workers and reported CNS symptoms that included 
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headache , vertigo , and sleep disturbances. In 1961, Adams and 
Crabt r ee indicated t hat anosmia (loss of the sense of smell) occurs 
in humans exposed to heavy dust environments in alkaline battery 
factories. 
In laboratory animals there is evidence of cadmium initiating 
neurolog i cal disturbances. Gabbiani et al. (1967) gave one sub-
cutaneous injection of CdC1 2 to rats and rabbits a t various t ime 
intervals after birth and found that lesions were detected in the 
nervous system only in animals t reated at a very young age , mature 
animals appeared t o be insensitive to the cadmium trea tment . 
Parenteral administ r ation of cadmium, at a low dose (10 ppm) t o ra t s 
5-6 weeks old with a gradual increase in treatment until the maximum 
dose (40 ppm) was reached at 14 months of age and maintained at 
this level for an additional 17 months , was found to produce slight 
leg weakness (Sato, 1975). Pathological changes were detected in 
the spinal peripheral nerves while being absent from the central 
nervous system. An additional study (Sato et al., 1978) that included 
the same treat ment regimen and utilized electron microscopy revealed 
segmental demyelina tion in the sciatic nerve beginning a t t he nodes 
of Ranvier with active autophagocytosis of Schwann cells containing 
myelin remnant s and dense bodies. Rastogi et al . (1977) examined 
t he effects of cadmium adminis te red to rats for 30 days, with 
exposure starting at birth, and detected an increase in tryosine 
hydroxylase and tryp tophan hydroxylase activities in specific brain 
regi ons . At t he low dose endogenous levels of NE , DA, and 5- HT 
failed to change in the var ious brain regions examined and the authors 
suggested that the increase in synthesis of the neurotransmitters 
possibly led to an increased utilization of these compounds that 
produced the symptomatic effects. At ·the high dosage level a 
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slight increase in turnover of the brain amines was noted as well 
as an enhancement of the DA and NE levels in several brain regions. 
The authors felt that their study indicated that cadmium acts at 
some point in the metabolism of the biogenic amines to increase 
intracellular synthesis and turnover. In contrast with this 
information Hrdina et al. (1976) found that cadmium exposure for 
45 days at 1 . 0 mg/kg/day significantly decreased 5-HT concentration 
in the brain stem of treated rats as well as induced a transient 
enhancement of striatal DA levels. Of special significance was the 
finding that the 5- HT decrease persisted even after a 28-day 
withdrawl from treatment. All biochemical changes were noted prior 
to the onset of overt neurotoxic symptoms. 
Although the studies of Rastogi et al. (1977) and Hrdina et al . 
(1976) have qualitative differences in the manner that cadmium 
effects the neurotransmitter levels, both studies provide evidence 
for cadmium affecting the nervous system under appropriate conditions. 
Whichever effect turns out to be correct or if both can actually 
be produced but under different conditions, it must be realized 
that the neurotransmitter system is of critical importance for 
no rmal nervous function. 
Selected Aspects of Acrylamide 
Neurotoxic ity 
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Exposure of experimental animals to acrylamide results in the 
development of delayed neuropathic lesions of the peripheral nervous 
system (Fullerton and Barnes, 1966; Prineas, 1969; Tilson and Cabe, 
1979). As in other delayed neuropathies, acrylami de toxicity produces 
a dying-back syndrome in which the lesion ascends the nerve tract 
in a centripetal direction on continual exposure to the toxicant 
(Cavanagh , 1964). However, in acrylamide neurotoxicity the axonal 
l esions are multifocal in nature and are not restr i!cted to the 
terminal of the longest and largest axons as is seen in other delayed 
neuropathies (Jennekens et al., 1979; Schaumberg et al., 1974). 
In the histological examination of neuromuscular junctions after 
acrylamide exposure, Tsujihata et al. (1974) observed the disappearance 
of some axonal terminals from the pre-synaptic regions but the 
preservation of other terminals within the same endplate region. 
Extending this work Jennekins et al. (1979) attempted to correlate 
morphological changes at the terminal arborizations of the neuro-
muscular junction with behavioral changes in rats, as exemplified by 
ataxia and hindlimb paralysis. Although multifocal swellings were 
observed in the muscle groups examined, there was no correlation 
between the frequency of these focal swellings and the behavioral 
changes. To account for this the authors speculated that other 
factors such as the involvement of pre-terminal motor axons, peri-
pheral sensory neurons and the central neurons may be of equal 
importance for t he development of c linical signs of acrylamide 
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neuropathy. They also felt that differences in the stages of various 
lesions were not due so much to the time of the initial insult as 
to the rate of r epair at any one site. This is in agreemen t with 
Spencer and Schaumberg's (1977) theory that acrylamide induced 
distal axonal degenerat ion is the result of 1) failure of the 
synthetic machinery in t he neuronal cell bodies, 2) impaired axonal 
transport , and/or 3) direct compromise of metabolic processes in 
the axons. 
Additional information is becoming available to support this 
theory. Protein synthesis, as assessed by the rate of leucine 
incorporation, is known to be inhibited in the nervous system 
(Schotman et al., 1977a) although a causal relationship was not 
demonstrated (Schotman et al . , 1977b, 1978) . Bradley and Williams 
(1973) were among the first to demonstrate acrylamide inhibition 
of fast axonal flow in cats with acrylamide induced neuropathies . 
Although no supportive information has been found, Schoental and 
Cavanagh (1977) proposed tha t toxic substances such as acrylamide 
might gain entrance to. the nerve fibers at the axonal terminals 
or the nodes of Ranvier and inactivate enzymes or o t her cofactors 
involved in axonal metabolism. If the speculated binding to 
enzymes or cofactors was to occur the resupply would be least 
adequate at points distal to such lesions. 
Since any effects occurring in the axon or the neuronal cell 
body would ultimately be expressed in the nerve terminal it is 
possible that an examination of normal functions in the terminal 
might give an indication of the level of acrylamide exposure. 
Selected Aspects of Cyclodiene 
Insecticide Neurotoxicity 
21 
Cyclodine insecticides, the group to which Kepone belongs, are 
often considered t o possess less acute toxicity but greater potential 
for chronic toxicity than the organophosphates and carbamates (Allen 
et al., 1979). Principle symptoms of acu t e poisoning are g~nerally 
characteristic of central nervous system effects; hyperexcitability, 
tremors and convulsions, with the convulsion usually but not always 
preceeding ot her signs of toxicity (Wooley, 1976; Allen et al., 1979). 
Attempts have been made to correlate behavioral changes, produced 
after cyclodiene exposure, with concurrent changes in the levels of 
biogenic amines (McGeer, 1971). Sharma (1973) and Sharma et al. 
(1976) reported that dieldrin reduced levels of NE, DA, and 5-HT in 
mallard ducks at the same time that changes in aggressive and 
confrontation behavior were observed. Other studies have indicated 
a speCies difference in the reduction of brain amine concentrations·, 
principally catecholamines; positive effects were seen in rats after 
a-chlordane exposure (Hrdina et al., 1974) while the levels of the 
biogenic amines were unchanged in mice after dieldrin treatment 
although 5-hydroxyindolae~etic acid (5-HIAA) , a 5-HT metabolite, 
was increased sugges ting an effect on 5-HIAA efflux from the brain 
(Sharma, 1976). At present there is too little information available 
to speculate whether an alteration in biogenic amine levels after 
treatment with cyclodiene insecticides has a causal relationship 
to the primary CNS lesion. 
In spite of the well documented neurological signs observed in 
cyclodiene poisoning histological alterations in the CNS are relatively 
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slight or non-existent (Hodge e t al ., 1967) . At t he same time the 
cyclodienes are known t o affect the conduction of the action 
potential withou t altering the resting membrane potential of the 
nerve fiber (Wooley, 1976). Together t hese studies suggest tha t the 
cyclodienes might produce a functional modification of normal synaptic 
activity leading to the expression of the neurological symptoms . To 
date ver y little information is available in the literature examining 
such a hypo t hesis . 
Recently though, Kepone has been shown to stimulate the release 
of neur otransmi tters from synaptosomes by prevent ing Ca++ sequestra-
tion in mitochond ria which normally would lead to reestablishment of the 
resting membrane potential (En~ et al . , i979a). End et al. (1979b) 
also reported that Kepone and KCN stimulated rat synaptosomal Ca++ 
efflux by releasing mitochrondrial stores . While KCN efflux 
proceeded via Na+-Ca++ exchange across the plasma membrane Kepone 
release of Ca++ was independent of the Na+-Ca++ or Ca++- Ca++ 
channels suggesting that a direct membrane perturbation initiates 
this release. To support t h i s hypothesis the study also found that 
Kepone releases synaptosomal lacta te dehydrogenase as does KCN, 
electron microscopic examination of these synaptosomal preparations 
show the Kepone exposed samples undergoing membrane lysis while the 
KCN treated preparations incurring only minor swelling. 
In an examination of the transport processes leading to 
inactivation of the bi ogenic amines released into the synapse,Ho 
et al. ( 1980) report a decrease in dopamine and norepinephrine uptake 
into mouse brain synaptosomes exposed to Kepone in vivo or in vitro . 
23 
Kepone was shown to decrease the affinity of DA for the ligand as 
well as the maximum amount of DA bound in b;th in vivo and in vitro 
--- ----
treated preparations. The effect on NE was the same as DA in vitro 
----
but the NE affinity in vivo was not significantly different from 
the controls although the total uptake was reduced. 
The above information indicates that at least one of the 
cyclodiene insecticides is capable of modulating synaptic function, 
although additional work is necessary to determine the relationship 
of this effect to the clinical symptoms. 
Metabolic and Functional Characterization 
of Synaptosomes 
Synaptosomes are synaptic terminals which have been sheared, 
during fractionation, from their axonal connections and surrounding 
glial cells. After separation from the axon the terminal reseals 
forming an intact structural unit (Jones, 1975). Often the inter-
synaptic cleft and post-synaptic processes are isolated as a portion 
of the unit. Gray and Whittaker (1962) utilizing differential and 
density-gradient centrifugation were the first to isolate and 
identify synaptosomes. Synaptosomes sediment with mitochondria and 
because of their size were overlooked during early sucellular fraction 
studies on brain tissues. 
Since the discovery of synaptosomes a considerable effort has gone 
into the elucidation and characterization of the biochemical mechanisms 
retained after separation. Johnson and Whittaker (1963) showed that 
synaptosomes contain a significant portion of the lactate dehydrogenase 
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and potassium of the tissue homogenates. This suggested that the 
synaptic terminal resealed after shearing and loss of soluble 
cons tituents was limited. Bradford (1969) incubated synaptosomes 
in vitro in appropriate media and demonstrated normal respiratory 
function . With glucose and pyruvate as substrates a high resp irat ory 
activity was seen. On exposure to hypotonic solution respiration 
diminished and became non- linear. ATP and phosphocreatine were 
synthesized with glucose as substrate. Synaptosomes showed an active 
accumulation of potassium from the media . In a comparison of rat 
synaptosomes and brain slices Bradford and Thomas (1969) showed that 
both preparations were able to carry out similar metabolic functions . 
Glucose was conver ted to lactate, aspartate, glutamate, glutamine, 
alanine, and t-amino butyric acid (GABA). Pool sizes of these 
amino ~cids were greater in cortex slices than in synaptosomes while 
leakage of the amino acids from synaptosomes into the media was not 
seen providing additional evidence for the intactness of the 
membrane . 
To qualify synaptosomes as models suitable for the study of 
neurotranmission it is necessary to demonstrate the existence of 
a trans - membrane potential. Due to their small size, 0 . 5 ~m , direct 
measurement of membrane potential is difficult and it becomes 
necessary to establish its existence by inference. Application of 
electrical pulses to synaptosomal preparations gives rise to 
+ increased me tabolic rates, loss of K and differential loss of 
physiologically active amino acids (Bradford et al., 1973). This 
+ 
same study also showed t he loss of synaptosomal K and amino acids on 
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exposure to depolarizing concentrations of K . An active accumula-
tion or extrusion of various ions supports the existence of a 
trans- membrane potential . Ling and Abdel- Latif (1968) demonst r ated 
the active removal of Na+ from synaptosomes while K+ (Bradford, 
1969) and Ca++ (Lust and Robinson, 1968) are actively accumulated . 
Whi t take.r (1969) in anticipa t ion of the evidence revealing 
synaptosomes to be metabolically functional and to have physiologically 
active memb rane activity described synaptosomes as "minature non-
nucleated cells" . Investigations of neurotransmitter release and 
uptake add support for this concept . 
Electrical stimulation and depolarizing K+ concentrations were 
shown to be responsible for the release of acetylcholine from 
synaptosomal suspensions (Haga, 1971). DeBelleroche and Bradford 
(1972) utilized s ynap t osomal beds (deposits of the ner ve endings 
between nylon gauze to r educe t issue:fluid ratios) to support the 
evidence for acetylcholine release and found that this release was 
enhanced following electrical or K+ stimulation . In Ca++- free media 
acetylocholine released in t o the incubation medium was reduced. 
Ca++-dependent norepinephrine loss from synaptosome to the medium 
was also observed on electrical or K+ induced depolarization 
(Blaustein et al . , 1972). 
Membrane ac tive transport processes have been demonstrated for 
cations, amino acids and biogenic amines , Kurokowa et al. (1965) 
in one of the first studies on synaptosomes, examined the Na+, K+-
dependent adenosinetriphosphatase activity of the membrane . They 
showed guinea pig synaptosomes accumulated K+ and extruded Na+ 
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against concentration gradients . Oubain and p-chloromercuri-
benzoate inhibited this enzyme function in a manner quantitatively 
similar to that seen in other tissues . L-Glutamate and GABA 
exhibited net upake in depolarized synaptosomal fractions that are 
Na+ and temperature dependent (Roskoski, 1978) . Depolarazing media 
was used for the assay to reduce the homoexchange of synaptosomal 
and exogenous L- glutamate or GABA . Depolarization of synaptosome 
preparations with KCl was shown to accelerate choline uptake over 
the control rates (Roskoski , 1977). The neurotransmitter biogenic 
amines undergo active uptake after release from synaptosomes. Garey 
and Heath (1974) prepared synaptosomesfrom post- mortem human brain 
tissue, 4- 8 hours after death, and measured the levels of cate-
cholamine uptake . Active uptake was seen in all samples . For 
comparison, synap t osomes prepared from rats, l or 12 hours after 
sacrifice, demonstrated active uptake at both time intervals. 
Kuhar et al. (1972) examined the transport of serotonin, dopamine and 
norepinepherine in rats with a nd without Raphe lesions. In all cases 
active accumulation was seen with serotonin being the only trans-
mitter to have an altered uptake in treated animals. 
Utilization of synaptosomes as a model for the investigation of 
neurotransmission has several advantages. First, the integrity of the 
membrane and demonstration of its functional capacity is comparable 
to the in situ condition at the synapse. Secondly, the characteri-
zation of their metabolic activity indicates that all enzymes and 
co- factors are present as would be seen in situ . Thirdly, the 
studies showing the viability of synaptosomes for several hours after 
removal from the brain allows for time related studies . A final 
advan t age would be the characterization of synaptic activity away 
from the diluting factors seen with tissue homogenates . 
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MATERIALS AND .METHODS 
Animals 
Simonsen derived Sprague-Dawley male rats, 150-300 grams 
(Simonsen Labo ratories, Inc., Gilroy, CA) were used for all 
synaptosomal preparations . Housing conditions consisted of a 12-
hour day-night cycle and five animals per cage with food and water 
Chemicals 
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Ficoll for the discontinuous gradient was obtained from 
Pharmacia (Uppsala, Sweden). The following chemicals were purchased 
from Sigma Chemical Company (St. Louis, MO); albumin recrys tallized 
from Bovine serum, 3-0-methyl fluorescein, 3-0-methyl fluorescein 
phosphate, S-Nicotinamide adenine dinucleotide, reduced form (NADH), 
and ouabain. Chlorpromazine was obtained from Smi th, Kline, and 
French Labs. (Philadelphia , PA). Sources, purity, and chemical 
names for all test compo unds are listed in Table 1. De-ionized water 
was used for all procedures that required water as a diluent. 
The radio-labelled amines were purchased from New England 
Nuclear Corporation (Boston, MA) and were supplied with the following 
specific activities, 5-1,2-3H(N)-Hydroxytryptamine creatinine 
sulfate, 29.6 Ci/mmol and DL-7-3H(N)-Norepinephrine, 15.2 Ci/mmol. 
Table 1. Test compounds used for synaptosomal uptake and K +-dependent phosphatase studies . 
Compounds 
Hethyl mercuric c hloride 
Mercuric nitrate 
Cadmium chloride 
Kepone 
Ac rylamide 
Diisopropyl fluorophosphate 
(DFP) 
Paraoxon 
Chemical Name 
or Structure 
CH 3HgCl 
Hg(N03) 2 
CdC12 
decachlorooctahydro-1,3, 
4,-metheno-2H-cyclobuta 
(cd}-pentalen-2-one 
CH2=CHCONH 
phosphorofluoridic acid 
bis(l-methylethyl) ester 
diethyl-p-nitrophenyl 
ester phosphoric acid 
Source Grade 
Alfa Division 95+% pure 
Fisher Scientific Co. Reagent grade 
Fair Lawn, NJ 
J, T. Baker Chemical Co. Reagent grade 
Phillipsburg, NJ 
U.S. Environmental 88% pure 
Protection Agency, 
Toxicology Division 
Research Triangle Park, NC 
Eastman Kodak Co. Reagent grade 
Rochester, NY 
Sigma 'Chemical Co. Analytical grade 
St, Lo uis, MO 
American Cyanamid Co. Practical grade 
Agricultural Division 
Princeton , NJ 
N 
<0 
Preparation of "Modified Crude Mitochondrial" 
Fraction (MCM) 
The preparation of synaptosomes followed the procedure of 
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Cahill and Medzihradsky (1976) with the addition of a few modifi-
cations to increase the yield of synaptosomal fraction. All tissue 
procedures were carried out at 0-40C in an ice- bath. Five rat brains 
were removed and placed in ice- cold 0 . 32 M sucrose, immediately after 
sacrifice. Cerebral cortices were dissected free from the whole brain, 
combined, weighed, minced, and homogenized in 0.32 M sucrose at a 
concentration of 10 percent (w/v) in a 50 ml Potter-Elvehjem homo-
genizer equipped with a teflon pestle. The homogenate was then 
centrifuged at 0- 4°C for 15 minutes at 3,000 x g, in an International 
high speed refrigerated centrifuge model HR- 1 equipped with a fixed 
angle rotor, to remove blood, nuclei and cell debris. The resulting 
supernatant was cetrifuged at 15,000 x g for 25 minutes and sub-
sequently divided into three fractions. Fraction 1, supernatant; 
fraction 2, upper portion of pellet characterized by a white layer 
having the appearnce of a ring or "halo" on top of fraction 3, a 
firm yellow pe l let. Fraction 2 and 3 when combined represented the 
crude mitochondrial fraction that contained mitochondria, synaptosomes 
and myelin fragments . Fraction 1 was remo ved with a pasteur pipet and 
saved , fraction 2 was also extracted and represents a modified crude 
mitochondrial fraction (MCM) enriched in synaptosomes (Cahill and 
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Medzihradsky , 1976), t his f r action was also saved. Fraction 3 was 
then diluted with 10 ml of 0.32 M sucrose and re-centrifuged along 
with frac tion l and 2 at 15,000 x g for 25 minutes. Supernatants 
from all three fractions were then removed and discarded while the 
''halo" that layered the pellet of fraction three was removed and 
combined with the pellet of fraction two. The comb ined fractions 
were re-centrifuged at 15,000 x g for 25 minutes after which the 
supernatant was discarded and t he pellet was t hen combined wi t h the 
pr evious pellet of fraction l which had been diluted with 0.32 M 
sucrose (0 .5 ml /cerebral cortex) . This final MCM suspension was 
t hen gently hand homogenized in a glass Dounce homogenizer in the 
final step of the preparation. In the procedures outlined by 
Cahill and Medzihradsky (1976) only the "halo " of the initial 
15,000 x g pellet was saved while the supernatant and the firm 
yellow pellet were discarded. By retaining these fracti ons t he 
ultimate MCM y ield was increased indicating a more nearly comple t e 
recovery of synap to somes. Total preparation time from r emoval of 
brain to final MCM was 3 hours. A flow diagram of the synaptosome 
preparation is given in Illustrat ion l. 
Density-Gradient Separation of Synaptosomes, 
Mitochondria and Myelin Fragments 
Where it was necessary to separate the homogenate into puri f ied 
f rac tions of synap t osomes, mitochondria and myelin a procedure 
utilizing density-gradient centrifugation, was outlined by Kurokawa 
et al. (1965) , was used. After t issue homogenazation the homogena te 
was prepared as indicated above, through the first 15 , 000 x g 
Resuspend in 
10 ml 0.32 11 
Pellet 
supernatAnt 
(dlsc:nrd) 
Pdh:t 
Homogenate 
lOZ (Y/v) in 0.32 M sucrose 
Pelltot 
(discard) 
15,000 xg 
(25 min) 
combine 
15 , 000 Ill: 
(25 111in) 
Supernntant 
(dhcnrd) 
1101 
reJ let 
1,000 11g (U min) 
Supe-rnatant 
15,000 11g 
(25 min) 
~upernnta nt 
(dt11c:nrd) 
Final 
M01 
I ... ~ .. , ..... , 
Pellet 
Supernatant 
15,000 J:g 
(25 min) 
Supernatant 
(discard) 
Resuspended in 
0 .3 2 H (Oiucrose , 
0.5 ml /b rain 
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Illustration 1. Flow char t fo r isolation of MCM fraction from rat 
cerebral cortices. 
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centrifugation, at this point the entire pellet, crude mitochondrial 
fraction (fraction 2 and 3), was diluted with 0.32 M sucrose to a 
concentration of 3 . 0 ml/gram of original tissue. A 1.0 ml aliquot 
of this suspension was then layered on a discontinuous density-
gradient, consisting of 2.0 ml of 3 percent (w/ v) and 2.0 ml (w/ v) 
Ficoll dissolved in 0.32 M sucrose, pre-chilled to 0-4°C. The 
gradients were then centrifuged at 20,900 x g for 15 minutes 
(International B- 60 Ultracentrifuge with a #487 SB-283 titanium 
swinging bucket rotor) resulting in the formation of three distinct 
layers, A, B, and C. The liquid phases of A and C were nearly 
transparent, whereas that of B was hazy. The interface between 
layers A and B was white while that between B and C was greyish-
white and the pellet, in layer C, was brown. 
Electron microscopic studies of Kurokawa et al . (1965) showed 
A to consist mainly of fragments of myelin sheaths, also present 
were a few small synaptosomes as well as other vesicular membrane 
fragments. Subfraction B was principally composed of synaptosomes 
with a heterogenous mixture of membrane fragments as well as an 
occasional mitochondria. Subfraction C consisted mainly of mito-
chondria but an occasional synaptosome, as well as assorted membranous 
fragments, were also found to be present. 
To separate the three layers each was extracted with a pasteur 
pipet and then centrifuged at 105,000 x g for 20 minutes. The 
supernatant was then discarded and the pellet resuspended in an 
appropriate medium . 
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Synaptosomal Assay for NE and 5-HT Uptake 
Within 15 minutes of the final step of the MCM pr eparation the 
as say for measu rement of NE or SHT uptake was started. The MCM 
fraction was kept at 0 . 32 M sucrose (0- 4°C) until just prior to its 
addition to the assay tubes. The assay was performed in 15 ml 
centrifuge tubes at 37°C with appropriate 0°C controls. Except for 
the actual incubation at 37°C all s t eps were carried out at 0- 4°C. 
As was needed for the uptake studies, 0.05 ml of the MCM suspension 
was transferred to 0 . 90 ml of assay buffer that included the compound 
to be studied, if appropriate. The assay buffer contained the 
following final concentrations (mM): Tris , 35; NaCl, 100; KCl, 
10; Mgso4 ·7H2o, 1.2; KH2Po4 , 1.2; NaHC03 , 1.0; sucrose, 25; glucose , 
10; and ascorbic acid, 1.0; t he pH of the buffer was adjusted to 
7.4 with HCl. To start the assay, 0 . 05 ml of a radiolabelled 
compound, the activity of which was adjusted to 0.03-0 .10 ~Ci per 
0.05 ml, (the final specific activity was adjus ted by the addition 
of non-labelled NE or SHT as needed), was added to the appropriate 
tubes which were then incubat ed at 37°C in a shaking water bath 
for a predetermined length of time . At the end of the incubation 
time the samples were placed into the ice-bath and the radio-labelled 
biogenic amine was then added to the 0°C controls and all samples 
were centrifuged at 8,000 x g for 5- 7 minutes . After pelleting the 
synaptosomes the supernatant was removed and 1.0 ml of 0.4 N perchloric 
acid was gently added to each sample to extract the radio-labelled 
compound. Af ter three hours duplicate 0.2 ml aliquots were prepared 
for liquid scintillation counting in a Packard Tri-Carb 2660 liquid 
scintillation counter. 
35 
Protein was determined by the method of Lowry et al. (1951) 
for each group of samples using crystallaized bovine serum albumin 
as the standard. 
Assay for Lactate Dehydrogenase Activity 
Synaptosomal lactate dehydrogenase (E .C . 1.1.1 .2 7) activity 
was determined by the method of Bergmeyer and Bernt (1974) in which 
the disappearance of NADH is monitored over time. The assay was 
carried out in a cuvette with a 1.0 em light path and monitored at 
340 nm in a Perkin-Elmer, Coleman 124 doublebeam spectrophotometer. 
The total volume for the assay solution was 3.15 ml and consisted 
of t he following components and their final concentrations: phosphate, 
48 mM; pyruvate , 0.6 mM; NADH, 0.18 mM; and 0.1- 0.3 mg MCM protein. 
Tri t on X-100 (final concentration 0.1 percen t) was used t o determine 
intra- synaptosomal LDH activity while the LDH activity in the 
absence of Triton X-100 was considered to be extra- synaptosomal. 
The change in E340 was recorded every 60 seconds for 3.0 minutes 
to obtain an average value in the presence or absence of Triton X-100. 
Activities were calculated according to the following equation: 
€ x d x mg prot./ml ~moles NADH disappearing/mg prot./min 
E340 change in extinction at 340 nm 
d light path, 1 . 0 em 
NADH extinction coefficient, 6.2 cm2 /~mole 
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K+-Dependent Phosphatase Assay 
MCM was diluted with 250 mM Tris-HCl pH 7.4 to a concentration 
of app roximately 0.1 mg/ml to give a final protein concentration 
of 1.5-2. 0 ~g/ml . The 3-0- methylfluorescein phosphatase assay 
developed by Huang and Askari (1975) was used to monitor K+-dependent 
phospha tase (E.C . 3.6.1.3) activity and is based on t he determination 
of t he amount of fluorescence due to the formation of 3-D-methyl-
fluorescein. Fluorescence measuremen ts were made with an Aminco-
Bowman spectrofluorometer. The standard assay medium contained 
1.0 ~M 3-0-methylfluorescein phosphate, 1.0 mM MgCl 2 , 10 mM KCl, 
and 50 mM Tris-HCl pH 7.4 in a final volume of 3.0 ml. The fluoro-
meter was s tandardized wi th a 1. 0 ~ solution of 3- D- methyl-
fluorescein, to obtain a 50 percent fluorescence, in the same buffer 
solution that was used for the assay. The excitation and emission 
wavelengths were 465 and 518 nm, respectively. All assays were 
carried out at 37°C by pumping water from a waterbath through the 
cuvette chamber which was designed for such a circulating water 
flow. Blank readings were determined for 0.05-0 . 10 ml MCM in the 
assay buffer without the substrate. On addition of the 3-0-
methylfluorescein phosphate the change in fluo resc ence .was monitored 
on a strip chart recorder for two minutes. The change in fluorescence 
per time period was calculated and used in t he following equation 
to de termine the activity of the phosphatase: 
dX 1 60 
nmoles phosphate liberated/mg prot . /hour 50 x prot. x time 
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dX change in fluorescence reading for a specified time period 
50 emission of standard ( l ~M 3-0-methylfluorescein) 
prot. final concentration of protein in mg/ml 
time length of reaction in minutes 
Est i mation and Statistical Treatment 
of K and V Values 
m max 
K 
m 
and V 
max 
constants were calculated according to th e method 
of Wilkinson (1961) which incorporates t he determination of the 
statistical parameters from the experimental data. 
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RESULTS 
The objective of this s.tudy "(as to determine the iniluence 
various environmental pollutants have on synaptosomal inactivation 
of norepinephrine (_NE) and 5-hydroxytryptamine (5-HT). In order to 
accomplish this it was necessary to characterize the kinetics of the 
transport process as well as to determine the optimum conditions fo r 
such a characterization. Chlorpromazine and ouabain were used as 
positive inhibitor s of the uptake process to help determine the 
suitability of the synaptosomal preparations used in this study. 
A K+-dependent phosphatase was also monitored in the synaptosomal 
membrane to determine the effects the test chemicals have on the 
Na+, K+ gradient which is required for optimum transport of NE 
and 5-HT. 
Characterization of NE and 5-HT Uptake 
Uptake versus protein concentration 
Since this study required the preparation of numerous MCM 
fractions it was necessary to determine if the NE and 5-HT uptake 
processes possessed a linear relationship over the range of protein 
concentrations used. Figures 1 and 2 indicated that such a relation-
ship existed and that the uptake process had an initial linearity 
which was lost at higher protein concentration. All uptake studies 
were performed within the demonstrated range of linearity. 
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Figure 1. Representative presentation of the relationship between NE uptake into MCM 
fraction and MCM protein'concentration. The uptake assay was performed with 
0 . 5 ~M NE at 370C for 5.0 min . 
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Figure 2. Representative presentation of the relationship between 5HT uptake into MCM fraction 
and MCM protein concentration . The uptake assay was performed with 0.1 ~M 5HT 
at 37°C for 3.0 min . 
6 
41 
Uptake versus time 
In assessing the optimum condition for the up t ake s t udy it was 
necessary to determine the time dependency of the transport 
processes in the MCM preparations . The specific activity of the 
NE up t ake reached a maximum at 10 minutes while the 5-HT uptake 
reached its peak value at 4 minu t es (Figure 3). NE uptake increased 
curve- linearly for the firs t 5 minutes at which time the linearity 
decreased and a plateauing occurred between 10 and 15 minutes 
5-HT uptake also had an early linear relationship between l and 4 
minutes but by 5 minues a decline in total uptake was observed. 
Since a time dependency existed for these two uptake systems the 
subsequent experiments were performed wi thin the linear segment. 
With NE a 5 minute assay time was used while 3 minutes was used 
for the 5-HT assay. TI1ese time periods were used throughout the 
remainder of the study. 
Estimation of kinetic constants 
The transport of biogenic amines into the pre-synaptic terminal 
is an active process with identifiable kinetic constants. Table 
2 lists the K and V values as determined for NE and 5- HT in the 
m ~x 
MCM preparations . 5- HT uptake was shown to have two transport 
processes while only one such process was identified for NE. 
The biphasic nature of the 5-HT uptake is readily evident in 
Figures 4 and 5. Figure 4 is a standard plot of substrate 
concentra t ion (5-HT) versus velocity (pmoles 5- HT/mg protein/min) 
and can be interpreted as showing the two phases of the 5- HT 
transport with the high affinity process occurring at concentrations 
Table 2. Kro and Vmax yalues for the 5HT and NE uptake into the 
MCM fraction . a,d 
5HT NE 
high affinity low affinity 
K b 0.40 ± 0 . 16 3 . 64 1.11 ± 0.26 
m 
v c 
max 
2 . 54 ± 0. 77 10.0 4.65 ± 0.47 
aKm and Vmax values determined by the method of Wilkinson (1961) 
buM 
cpmoles / mg protein/min 
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dEach value represents the mean± s. d. ob taine.d from 2 - 4 de t er-
minations involving 2 - 4 synaptosomal preparations except 5HT low 
affini t y Kro and Vmax values which were obtained from only one 
MCM preparation. 
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Figure 3. Time dependence of biogenic amine uptake into MCM fraction. The data presented 
for NE (0----0) and SHT (t----1) are representative experiments performed with 
0.5 ~M NE and 0 . 1 ~M SHT. 
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Figure 4. Standard substrate vs velocity plot for 3H-5HT uptake 
into a MCM fraction . The data points indicate the 
presence of two transport processes, Km and Vmax values 
obtained for both processes are presented in Table 2. 
Each point is the mean of 2-4 determinations involving 
2-4 separate MCM preparations. Assay performed in 
duplicate at 37°C for J . Q. min with simultaneous 0°C 
con t rols. 
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Figure 5. Lineweaver-Burk plot of the uptake data for 3H-5HT 
presented in Figure 4. The obtained Km and Vmax values 
are presented in Table 2. Crossbars designate the S.E.M. 
of the data collected from 2- 4 MCM preparations. Circles 
without bars represent individual observations. 
below 0.25 ~M and the low affinity uptake operating above 5-HT 
concentrations of 0.5 ~M. Using a Lineweaver-Burk reciprocal 
plot of 1/v versus 1/S (Figure 5) a mo re accurate estimation of 
the Km and Vmax was obtained. With this approach the Km and Vmax 
for the high affinity uptake were ·calculated as 0.45 ~M and 2.86 
pmoles/mg protein/min, respec tively . The low affinity uptake 
was determined to have a Km of 3.64 ~M and a Vmax of 10 pmoles/mg 
protein/min. The distinction between these two processes is 
evident with the intersection of the two lines in Figure 5. 
NE concentrations ranging f r om 0.05-10 ~M were used t o ob t ain 
the information that is graphically presented in Figures 6 and 7. 
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A smooth perpendicular right-handed hyperola is obtained in Figure 6 
in a plo t of substrate concentration ve rsus velocity a nd suggests 
that first-order kinetics are approp ria t e at low s ubstrate (NE) 
concentrations. By replotting this data on a reciprocal plot of 
1/v verus 1/S (Figure 7) the ~ and Vmax we r e identified as 1.11 ~M 
and 4.65 pmoles NE/mg pro t ein/min, respectively . A single set of 
kinetic constants were obtained indicating the existence of only 
one uptake process for NE in synaptosomes. 
The concentrations of 5-HT and NE used fo r the majority of 
t his s t udy were based on the Km values described above. For 5-HT 
0.1 ~M was the con centration chosen while 0.5 ~M was used for all 
experiments involving NE uptake . 
Localization of NE after incubation 
in MCM preparations 
MCM preparations were enriched in synaptosomes but cont ained, 
to a lesser extent , mitochondria and various types of membrane 
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Standard subs trate vs velocity plot for accumulation 
of 3H- NE a t various concentrations into MCM fractions. 
Each point represents the mean of 2-4 determinations 
involving 2-4 different MCM preparations. Assays 
performed in duplicate at 370C for 5.0 min with 
simultaneous 0°C controls. 
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fragments (Cahill and Medzihradsky, 1976). Several experiments 
were performed to determine if the non-synaptosomal components were 
competing with synaptosomes for the NE or 5-HT used in the uptake 
studies. In Table 3 the results of purifying the MCM preparation 
after exposure to NE indicate that greater than 95 percent of the 
NE retained in the preparation after assay was found in the synapto-
some fraction (B). Less than 5 percent was found in the mito-
chondrial fraction (C) while the myelin fraction (A) had no 
measurable retention of the NE . In this study the assay buffer was 
without pargyline, a monoamine oxidase inhibitor, which would have 
prevented rnitochrondrial metabolism of the NE. However, in Table 4 
the NE and 5-HT uptake was measured in the presence of pargyline. 
In these experiments pargyline did not increase the biogenic amine 
uptake into synaptosornes by inhibiting mitochondrial metabolism 
of these compounds and thus increase amine concentrations available 
to synaptosomes. The information presented in Tables 3 and 4 indicate 
that the contaminating elements of the MCM preparations did not 
interfere with synaptosomal uptake of NE or 5-HT . 
Lactate Dehydrogenase Activity as a Normaiization 
Factor Between MCM Preparations 
Since many MCM preparations were used for this study it was 
necessary to determine the degree of membrane intactness between 
preparations in order to assess the feasibility of directly comparing 
data from each preparation . To accomplish this, lactate dehydrogenase 
activity (LDH) was monitored in several preparations. LDH measurements 
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Table 3. Localization of 3H-NE after uptake into a synapotosomal 
preparation. 
Gradient a 12moles NEb Composition 
fraction 0°C 37oc Difference 
A 0.02 NDd ND myelin and 
various mem-
brane fragments 
B 0.68 8.50 7.82 synatposomes 
c ND 0 . 34 0.34e mitochondria 
aUptake assay performed as described in methods after which MCM 
pellet resuspended and layered on a 3 - 13% discontinuous ficoll-
sucrose gradient. 
bValues obtained were assayed at the indicated temperature and are 
expressed as pmoles NE/rnl. 
cComposition .determined by Kurokawa et al. (1965). 
dND indicates radiolabel was not detected. 
e4.5% of fraction B. 
51 
Table 4. Effect of pargyline on NE and SHT uptake into MCM 
fraction. 
Pargyline (M) SHT or NE 
0 5HT (0.1 x 10-6 M) 
10-s 
10-4 
0 NE (0 .5 x 10-6 M) 
10-4 
5 X 10- 4 
aUptake determined in one MCM preparation. 
Amine Uptakea 
pmoles/mg protein/min 
0.48 
0.38 
0.46 
3 . 08 
2.38 
0.58 
were determined for the extra- and int ra-synaptosomal compartments. 
Since synaptosomal concentrations varied between preparations the 
monitoring of LDH activity in both compartments enabled batch 
comparisons to be made by using the extra- to intra-synaptosomal 
ratio (extra/intra) as an indicator of synaptosomal membrane 
in t egrity. In Table 5 the synaptosomal LDH ratio is less than 0 . 15 
in eight of the nine preparations indicating a very intact and non-
permeable membrane. The 5- HT uptake was determined in each of these 
preparations and the information in Table 5 shows that this activity 
is very similar in all preparations . The correlation coefficient 
obtained when comparing the LDH ratio t o the 5- HT uptake is 0 . 043 and 
indicates t ha t such a correlation does not exist. 
Chemical Influence on NE and 5- HT Uptake 
Chlopromazine and ouabain were used as positive controls for 
validating the functionality of t he synaptosomal preparations . Data 
in Figure 8 indicates that chlorpromazine inhibited the synap t osomal 
uptake of NE and 5- HT. The Ic50 (the concentration of test chemical 
t ha t inhibited the uptake by 50 percent) for bach processes were 
similar with 50 percent inhibition of NE up t ake occurring at 
1 . 1 x 10- 5 M wh i le 5-HT uptake was inhibited by 50 percent at 3.2 x 
- 5 10 M. Although the Ic50 •s were nearly iden tical the shape of the 
two curves were dissimilar. In Figur e 8 the NE process is below 
control levels between 10- 6 - 10- 4 M chlor promazine . With 5- HT 
uptake chlorpromazine was effec tive in a much narrower range 10- 6- 10- 4 
M and the slope of the line is much steeper than that seen with the 
NE process . 
Table 5. Corre l ation of 5HT uptake with the MCM Lactate 
Dehydrogenase activity. 
MCM Preparation LDH ratio a 5 HT 
l 0 . 285 0 .69 
2 0.132 o. 72 
3 0.146 0 . 91 
4 0.124 0.69 
5 0.101 0 . 70 
6 0.059 0.69 
0 . 092 0. 72 
8 0.117 0. 75 
9 0.123 0.059 
uptake 
Mean: c 0.131 ± 0. 063 0. 72 ± 0.08 
Correlation coefficient: 0.043 
aRatio of extra-synap tosomal/intra-synaptosomal LDH activity, 
determined spectrophotometrically by the measurement of the 
conversion of NADH ~ NAD. 
b5HT uptake determined using 0.1 uM 5HT for 3 min at 37°C, 
activity expressed as pmoles 5HT/mg prot./min. 
cMean ± s. d. 
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Figure 8. Chlorpr omazine inhibition of the NE (0----0) and 5-HT 
( t----1) uptake into the synap t osomal pr eparations. 
Concentrations of the biogenic amines were NE, 0.5 JJM 
and 5-HT, 0.1 JJM . Crossbars designate S.E.M. for data 
from 3 MCM preparations, circles without bars represent 
individual observations. Horizontal dashed l i nes indicate 
conf idence limits f or control values . 
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Ouabain inhibition of the synaptosomal uptake processes was 
positive only for NE uptake, the 5-HT uptake was not affected. The 
-4 rc50 value for the NE transport was 1.1 x 10 M with an effective 
range occurring between 0.5 x 10-4-1.0 x 10-3 M (Figure 9). The slope 
obtained for NE uptake is a linear function of the ouabain concentration 
over the range tested. With the 5-HT uptake system control values 
were obtained between 10-6-10-3 m ouabain. 
In testing the effects several heavy metals have on the synapto-
somal tranport process i nformation presented in Figures 10 and 11 
and in Table 6 indicate that the two mercurials, CH3HgCl and Hg(N03) 2 , 
inhibited both the NE and 5-HT process while CdC12 had no significant 
effect on either process. The alkyl mercury compound, CH3HgCl, 
appeared to inhibit both NE and 5-HT uptake in a similar manner, as 
well as to a similar degree. rc50 •s for the uptake processes were 
NE, 1.1 x 10-4 M and 5-HT, 2.5 x 10-4 M. The actual effective range 
is quite small. Hg(N03) 2 , an inorganic mercurial, was not as 
effective an inhibitor of the transport systems. Although the rc50 
obtained with Hg(N03) 2 was within the same magnitude as the CH3HgCl, 
Hg(N03) 2 did not completely inhibit synaptosomal transport of NE or 
5-HT. At 10-3 M, CH3HgCl inhibition of the NE or 5-HT uptake was 
complete while the Hg(N03) 2 inhibition at the same concentration was 
only 50-65 percent complete. 
Kepone was capable of completely inhibiting both NE and 5-HT 
uptake as is indicated in Figure 12. rc50 values were estimated 
to be 9.4 x 10-5 M for NE and 3.3 x 10-4 M for 5-HT. The effective 
inhibition range was small for both processes, NE inhibition occurred 
between 0.5 x 10- 4-0.5 x 10-3 M Kepone and 5-HT inhibition was less 
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Figure 9. Contrasting effects of ouabain on the biogenic amine 
uptake into synaptosomes. NE (0----0) uptake was assayed 
at 0.5 ~M NE while 5HT (t----1) uptake was determined 
at 0.1 ~M SHT. Crossbars designate the S.E.M. for 
experiments from 2-3 MCM preparations, circles without 
bar represent individual observations. Horizontal 
dashed lines indicate confidence limits for control 
uptake. 
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Figure 10. CH1HgCl inhibition of synaptosomal biogenic amine 
uptake. NE (0----0) and 5-HT (1----t) uptake were 
followed using 0.5 uM and 0.1 uM 5-HT, respectively. 
Crossbars are the S.E.M. for 2 MCM preparations while 
horizontal dashed lines designate the confidence limits 
for the control uptake. Circles without bars 
represent individual observations. 
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Figure 11. Hg(N03l2 influence on MCM NE (0----0) and SHT (t----1) 
uptake . NE uptake was measured in the presence of 
0 . 5 ~M NE while 0.1 ~M SHT was used for the SHT assay. 
Crossbars designate S. E.H. for data collected from 2-3 
MCM preparations, horizontal dashed lines indicate 
confidence limits for the control uptake. Circles 
without bars represent individual observations. 
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Table 6. Inhibitory influence of various environmental pollutants 
on synaptosomal uptake of NE and 5-HT. 
Chemical Concentration %. Control U]1take 
(M) NE SHT 
CH3HgCl 
10-3 0* 0* 
10-4 26* 100 
10-s 115 103 
Hg(N03) 2 10-
3 35* 47* 
10-4 lOS 90 
10-5 94 93 
CdC12 
10- 3 95 113 
10-4 77 149 
10-5 94 106 
Kepone 10-3 0* 0* 
10-4 49* 86 
10-5 95 112 
Acrylamide 10-3 88 70 
10-4 90 87 
10-5 88 73 
DFP 10-3 76 63 
10-4 91 79 
10-5 94 71 
Paraoxon 10-J 115 85 
10-4 113 90 
10-5 84 97 
*p<0 . 05 
~on-detectable 
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Figure 12. Kepone inhibition of NE (0----0) and SHT (1---1) 
synaptosomal uptake. 0.5 ~M NE and 0.1 ~M SHT were 
used for the assay . S. E.M. for the data collected in 
2-3 MCM preparations is indicated by the crossbars 
while the confidence limits for the control uptake is 
designated by the horizontal dashed lines. Circles 
without bars represent individual observations. 
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than control levels in the 10- 4- 10- 3 M range . As was already shown 
in Figures 10 and 11 for CH3HgCl and Hg(N03) 2 , respectively , the 
slope within the effective inhibitory range for Kepone was also quite 
steep. 
Table 6 lists several other chemicals that were tested for their 
ability t o inhi bit the synaptosomal transport processes. Acrylamide , 
DFP, and paraoxon were unable to produce a significant inhibition 
of either the NE or 5- HT uptake . Although acrylamide and DFP did 
inhibit the process 30-40 percent at the highest concentrations 
tes t ed , 10- 3 M, this was no t i nterp r eted as being significan t ly 
different from the control values. 
Chemical Influence on Synaptosomal 
K+- Dependent Phosphatase Activity 
In the assay for the K+- phosphatase activity of the synaptosomal 
membrane chlorpromazine was found to be an effective inhibitor of 
this enzymatic process (Figure 13) . The degree of inhibition was 
seen to be directly proportional to the chlorp romazine concentration 
of the assay . The graphical presentation of this effect shows a 
linear decrease in enzyme activity over the concentration range 
- 5 - 3 tested , 10 - 10 M. The IC50 for this inhibition was observed to 
occur at 8.4 x 10- 5 M chlorpromazine. Although the enzyme inhibition 
was dependent on the concentration of the drug it could not be 
determined from the data whether chlorpromazine was capable of 
producing a complete enzyme inhibition . 
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Figure 13. Measurement of synaptosomal K+- dependent phosphatase 
in the presence of various concentrations of chlor-
promazine. Enzyme activity determined at J70C with 
3-0-methylfluorescein phospha te (1.0 ~M) as substrate. 
S.E.M. for data collected with 2- 3 MCM preparations 
indica t ed by crossbars, circles without bars represent 
individual observations. 
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CH
3
HgCl was found to be a more potent inhibitor of the phos-
phatase activity than clorpromazine with an rc50 of 1.5 x 10-
6 M 
(Figure 14). The effective concentration range for inhibiting the 
- 5 -7 phosphatase activity was 5 . 0 x 10 - 1 . 0 x 10 M CH3HgCl. The 
concentrations used for this determination provide a well balanced 
group of values that indicated the synaptosomal enzyme activity to 
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be directly proportional to the CH3HgCl concentration of the assay . 
Hg(N03) 2 was determined to be the most potent inhibitor of the 
phosphatase. As can be seen in Table 7 it was 50 times more potent 
than either CdC12 or CH3HgCl, and 400 and 2600 times as effective 
as Kepone or chlorpromazine, respectively. Figure 15 reveals the 
initial inhibition to be related to the concentration of the 
compound in the assay while the lowest concentration of Hg(N03 ) 2 
tested, 3.0 x 10-8 M, sharply departed from the linear relationship. 
CdCl 2 was also a potent inhibitor of the K+-dependent phos-
phatase wi th an rc50 of 1.5 x 10-
6 M (Table 7). Figure 16 expresses 
the inhibitory relationship as being linear throughout the range 
~ ~ 
of concent rations tested (10 -10 M) . In comparing the CdC1 2 and 
CH 3HgCl inhibitions it was evident that their effects on the synap-
- 6 tosomal phosphatase activity was identical with the rc50 of 1.5 x 10 
M for each and the shape of the line connecting the points in Figures 
14 and 16 very similar. 
Kepone, at 3.33 x 10- 4 M, completely inhibited the phosphatase 
enzyme (Figure 17). The rc50 for this inhibition was 1.3 x 10-S M 
and Kepone, like chlorpromazine, CH3HgCl and CdC1 2 , inhibited the 
enzymatic cleavage of phosphate from the substrate in a manner that 
10 - 5 
Figure 14. Measurement of synaptosomal x+-dependent phosphatase 
activity in the presence of CH3HgCl. Phosphatase 
activity de termined at 37°C with 1.0 ~M 3- D-methyl-
fluorescein phosphate as substrate. S.E.M. for 
data collected from 2-3 MCM preparations indicated by 
crossbars. Circles without bars represent individual 
observations. 
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Table 7. Concentration of test compound producing 50 percent 
inhibition (ICso) of synap t osomal NE or SHT uptake or 
K+- dependent phosphatase activity. 
Chemical ICSO (uM) 
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NE SHT K+- dep . phosphatase 
CH 3HgCl 
Hg(N03) 2 
CdC1 2 
Kepo ne 
Acrylamide 
DFP 
Paraoxon 
Chlorpromazine 
Ouabain 
110 250 
400 600 
a 
94 330 
11 32 
110 
alnsufficient inhibi t ion for detection of rc50 . 
1.50 
0.03 
1.50 
l3 
84 
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Figure 15. Hg(N03)z inhibition of synaptosomal ~-dependent 
phosphatase. Enzyme activity determined at 370C 
with 1.0 ~M 3-0-methylfluorescein phosphate as 
substrate. S.E.M. for data collected from 2-3 MCM 
preparations indicated by crossbars . Circles wi.thout 
bars represent individual observations . 
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Figure 16 . Measurement of synaptosomal K+-dependent phosphatase 
in the presence of various concentrations of CdClz. 
Phosphatase activity determined at 37°C with 1.0 ~M 
3- 0-methylfluorescein phosphate as substrate. 
Crossbars designate the S.E.M. for data collected 
from 2- 3 MCM preparations . 
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Figure 17. Kepone inhibition of s ynaptosomal K+-dependen t 
phosphatase . as measured in the presence of 1.0 ~M 
3-0- methylfluorescein phosphate at 37oc. S.E.M. for 
data collected from 2-3 MCM preparat ions designated 
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by crossbars, circles without bars represent individual 
observations. 
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was proportional to the concentration of Kepone in the assay. 
Kepone exerted its inhibitory influence over a wide concentration 
- 7 - 3 
range, 10 - 10 M, which was also true for the other compounds that 
strongly inhibited this enzyme. 
The information presented in Table 8 shows acrylarnide, paraoxon, 
DFP and ouabain to be ineffective in depressing the synaptosomal 
phosphatase activity . Although ac r ylamide shows a 15 - 20 percent 
inhibition of this activity between 10- 6- 10-4 M and ouabain produces 
a 24 percent inhibition of 3.0 x 10-4 M these decreases were not 
found to be of statistical significance. 
+ Table 7 compares the rc50 •s for NE and 5-HT uptake and K-
dependent phosphatase activity. From this information chlorpromazine, 
used as a positive control for the uptake inhibition, had the lowest 
rc50 for both the NE and 5- HT transport processes while it was the 
least effective phosphatase inhibitor of the compounds that were 
able to reduce this activity more than 50% of the control. Hg(N03) 2 , 
on the other hand, was the least effective inhibitor of the uptake 
processes, of those inhibiting this function by more than 50 percent, 
yet it was the most effective inhibitory agent on the K+- dependent 
phosphatase by several orders of magnitude. Ouabain , another 
positive control, inhibited NE uptake but surprisingly was not 
effective against the 5- HT uptake mechanism or the phosphatase 
enzyme of the membrane. 
Table 8. Test compounds producing only mild inhibition of 
synaptosomal ~-dependen t phosphatase. 
Chemical Concentration (M) % Control 
Acrylamide 3.33 X 10- 5 87 
3.33 X 10-4 83 
Paraoxon 3.33 X 10-5 96 
3.33 X 10 -4 96 
DFP 3.33 X 10-4 97 
6.67 X 10-4 96 
Ouabain 3.33 X 10- 5 100 
3.33 X 10-4 76 
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DISCUSSION 
This study was undertaken to determine what influence a select 
group of environmental pollutants exerts on synaptosomal inactivation 
of norepinephrine (NE) and 5- hydroxytryptamine (5- HT). The test 
chemicals used in this study were CH3HgCl, Hg(N03) 2 , CdC1 2 , 
diisopropylfluorophosphate (DFP), paraoxon, acrylamide, and Kepone. 
In addition to the examination of the uptake process after in vitro 
exposure to the test compounds the Na, K+ gradient was indirectly 
monitored in the synapotsomal membranes by determining the K+-
dependent phosphatase activity in the presence and absence of the 
test chemicals. Since the uptake process is dependent on the 
transmembrane Na+ gradient the monitoring of this gradient was able 
to provide information to help assess whether the chemical influence 
on the memb rane transport process is specific in nature or the result 
of non- specific membrane interactions. 
Prior to the actual examination of the uptake activity in the 
presence of the test chemicals it was necessary to determine the 
suitability of the synaptosomal preparations for the study . This 
was accomplished by first determining the optimum conditions for 
the uptake assay (time, synaptosome concentration and neuro-
transmitter concentration) then by obtaining the Km and Vrnax for each 
uptake process . Once these Km and Vrnax values were obtained they were 
compared to the previously reported values of Cahill and Medzihradksy 
(1976). After this comparison chlorpromazine and ouabain were 
used as positive inhibitors of the membrane uptake to further 
determine the suitability of the synaptosomal preparations for use 
in this study. 
Suitability of the Synaptosomal 
Preparations for Up take Studies 
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Since the first isolation and characterization of synaptosomes, 
their usefulness for increasing the understanding of synaptic trans-
mission has been widely accepted. Most procedures for their isolation 
incorporate differential and density-gradient centrifugation as 
a necessary step in their purification. However, Cahill and 
Medzihradsky (1 976) devised a method which only requires differential 
centrifugation to isolate what they refer to as the "modified crude 
mitochondrial" fraction (MCM). They have shown this MCM fraction 
to be capable of carrying out the same functions as the more purified 
synaptosomal preparations. Not only does this procedure shorten the 
preparation time but it also reduces the handling of the synaptosome 
fraction and the possibility of membrane lysis that might occur under 
a more extensive isolation procedure. 
In Table 2 t he Km and Vmax for the transport of NE and 5-HT are 
listed. NE has a single high affinity process with a Km of 1.1 ~M 
and a Vmax of 4 .65 pmol es/mg prot./min. 5- HT uptake occurs via 
t wo separate transport phenomena wi th t he high affinity process 
being the most active at low substrate concentrations with a Km and 
Vmax of 0 . 40 ~M and 2.54 pmoles/mg prot./min, respectively. The 
low affinity uptake is characterized by a Km and Vmax of 3.64 ~M 
and 10.0 pmoles/mg prot./min, respectively. Cahill and Medzihradsky 
(1976) lis ted the Km for the NE up take as 0.39 ~M while the 5- HT 
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Km is 0.1 M for the high affinity uptake, Vmax's are 2.9 and 3.0 
pmoles /mg prot./min for NE and 5-HT, respectively . The quantitative 
difference between this study and the Cahill study may well be due 
to the manner in which the uptake assay's were terminated . This 
study employed a centrifugation step, after transferring the 37°C 
samples to an ice- bath, to pellet the synaptosomes while the Cahill 
procedure called for vacuum fil t ration as the terminating step in 
the assay. It is possible that the filtration technique allows for 
a more complete removal of any radio-labelled amine that is non-
specifically adhering to the synaptosomes than is possible by a 
similar clean- up procedure utilizing centrifugation. 
In assessing the subcellular distribution of NE after uptake 
into the MCM it was determined that greater t han 95 percent of t he 
amine was located in the synapt osomal fraction (Table 3). In 
conjunction with this finding is the demonstration that the addition 
of pargyline to the incubation media had no enhancing effect on NE 
or 5- HT uptake (Table 4). Since pa r gyline is a monamine oxidase 
inhibitor and as such would prevent the metabolism of NE or 5- HT 
by mitochondria , consequently increasing the amine concentration 
available for up t ake, this result is evidence that mitochondrial 
contamination of the HCM does not interfere to a significant extent 
with the synaptosomal uptake. 
The determination of the synaptosomal LDH ratio (intra- /extra-
synaptosomal) did not prove to be useful as a normalization factor 
for comparison of da ta from different sample preparations (Table 5), 
however, t his LDH ratio is useful if used as an indicator of memb rane 
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intac tness. The r a tios presented in Table 5 suggest that very intact 
synaptosomal membranes were present . Greater than 80 percent of the 
LDH activity occurred in the intra-synaptosomal compartment in almost 
all preparations. The data presented here indicate that the synapt -
osomes isolated for this study had a greater degree of membrane 
intactness than the synaptosomes used in the Cahill and Medzihradsky 
(1976) study where 30 percent of the LDH activity was present in the 
extra-synaptosomal medium. Although the LDH ratio is a good indicator 
of membrane integrity it unfortunatel y does not appear to be useful 
in assessing the functionality of the isolated synaptosomes. Because 
of this all uptake data is reported as percent of control uptake 
rather than a direct comparison of the actual uptake values. 
Chemical Influence on Synaptosomal Uptake 
Modification of synaptic inac t ivation of NE and 5-HT uptake 
is one means of producing behavioral changes in both animals and 
man. Chlorpromazine,. a commonly used anti- psychotic drug, is believed 
to work through such a mechanism (Brucke et al., 1969; Koelle, 1975). 
In this study a variety of environmental pollutants were tested for 
this activity and the results obtained indicate that several have 
such a capability. Table 7 lists the concentration of test chemical 
producing 50 percent inhibition of NE or 5-HT uptake for all the 
compounds investigated . The two mercurials, methylmercuric chloride 
and mercuric nitrate , and the cyclodiene insecticide Kepone were 
t he only compounds tested , other than t he positive controls, that 
were able to produce greater than 50 percent inhibition of this 
process . Acrylamide, DFP and paraoxon induce a slight bu t 
statistically insignificnt inhibition (Table 6). The rc50 values 
for the mercurials and Kepone were greater than 10-5 M indicating 
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that this inhibition is not specific for the carrier-mediated trans-
port of the biogenic amines. 
With respect to Kepone, End et al. (1979b) demonstrated a 
synap tosomal membrane disruption at 10-5 M that was characterized 
by a Ca++ efflux and leakage of LDH into the assay media. With 
electron microscopy they also noted that Kepone produced a direct 
membrane lysis that apparently led to the LDH and Ca++ liberation. 
In another study Ho et al. (1980) noted that Kepone decreased 
catecholamine and 5-HT uptake, after both in vitro and in vivo 
exposure, into mouse synaptosomes. Using a Scatchard analysis they 
revealed that Kepone reduced the affinity of the transmitter towards 
the ligand as well as the maximum amount of binding. These studies 
suggest that Kepone was able to alter the uptake of the biogenic 
amine in two ways, the first is membrane perturbation, resulting in 
a loss of the ionic gradient that is required for membrane transport 
thus reducing the effectiveness of the carrier- mediated process. 
The second mechanism is possible through a direct interaction of 
Kepone with the neurotransmitters membrane receptor ihibiting the 
transmitter binding to the uptake site. 
Mercurials are also known to specifically bind to membranes 
(Chang and Hartman, 1972c), in part this may be a function of their 
high affinity for sulfhydryl groups as well as a lesser affinity for 
amino, phosphate, carboxylate and hydroxyl radicals (Oehme, 1978). 
Mercury compounds accumulating in the region of the synapse would be 
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expected to readily associate with membrane components. Such an 
interaction could ultimately result in the loss of membrane function 
as is evidenced in th~s study of biogenic amine transport. Since 
the neurotransmitters have f unctional gr oups that are capable of 
complexing the mercury, direct interaction with the transmitter 
may enhance the inhibition of the uptake process. If such a direct 
interaction ~th transmitters was to occur physiologically in exposed 
animals the transmitter-metal complex would not only affect the 
inactivation process of the amines but would also have a specific and 
possibly more dramatic effect on post-synaptic interaction of the 
neurotransmitters and their membrane receptors . 
In examining the information contained in Figures 10, 11 , and 
12 it is noted that the mercurials and Kepone have a very narrow 
effective range (10-4-10-J !1) where significant uptake inhibition 
is detected . Such a narrow concentration range is suggestive of an 
all - or- none mechanism where uptake inhibition occurs only after high 
enough concentrations are present t o produce membrane perturbations. 
If complexing of neurotransmitter and toxicant were occurring it 
would be expected that a muc h greater dose- response effect would be 
seen . Extending the relationship further it might be argued that 
these chemicals do not produce a chronic toxicity by acting at the 
synapse because the hi gh concentrations required to disrup t the 
system are higher than one might expect to accumulate during chronic 
low- level exposures . 
With the other compounds, DFP, paraoxon , acrylamide and CdC12 , 
a direct effect to influence synaptosomal uptake of t he trans-
mitters does not appear to occur . A significan t modification of the 
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uptake process was not seen wh'en tested for in the presence of these 
compounds. For DFP and acrylamide this is somewhat unexpected 
considering they both appear to act, at least partially, at the 
membrane level in eliciting a toxic response. DFP is known to 
readily phosphorylate membrane components (Johnson and Lauwerys, 
1969) and it might have been anticipated that such phosphorylations 
would affect the uptake process, if not directly then indirectly 
by influencing the synaptosomal energy generation that is apparently 
required for membrane transport to occur. Although acrylamide 
initiates axonal degeneration it is still undecided whether this 
is a direct membrane effect or an indirect result of inhibition of 
axonal respiratory enzymes as recently suggested by Spencer et al. 
(1979). 
K+-Dependent Phosphatase Nodification 
by Environmental Pollutants 
K+-dependent hydroloysis of organic phosphate is catalyzed by 
membrane preparations highly enriched in (Na+,K+)-activated 
adenosinetriphosphatase (Na+, K+-ATPase) (Bader and Sen, 1966; 
Judah et al., 1962). Nore recently it has been found that in the 
purification of the Na+, K+-ATPase enzyme, from a variety of different 
+ 
sources, the K -dependent phosphatase activity remains associated 
with the enzyme and is actually purified along with it (Jorgensen 
et al., 1971; Pitts et al., 1973; Uesugi et al., 1971). In fact, 
it has been accpeted that the K+- dependent phosphatase activity is a 
property of the Na+, K+-ATPase (Hokin et al., 1973; Kyte, 1971; 
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Lane et al., 1973). Monitoring of this enzyme activity in synapt-
osomal preparations, and in the presence of the environmental 
pollutants investigated in this study, gives an indication of the 
influence that these chemicals have on the Na+ gradient required for 
synaptosomal membrane transport. 
Table 7 indicates that the heavy metal CH3HgCl, Hg(N03) 2 and 
CdC1 2 as well as Kepone and chlorpromazine produced greater than 
50 percent inhibition of this enzyme. Hg(N03) 2 is considerably more 
potent in this respect than the others, but CH3HgCl and CdC12 also 
strongly inhibit the phosphatase at very low concentrations. This 
is in general agreement with other workers who indicate that heavy 
metals are very e f fective in modulating Na+, K+- ATPase activity (Bond 
and Hudgins , 1979; Henderson et al., 1971; Karlish et al . , 1979; 
Kinter and Pritchard , 1977). Kepone inhibition of the phosphatase 
activity is also in agreement with the finding that, as a class, 
organchlorines are effective inhibitors of ATPase (Glick, 1973). 
Chlorpromazine was the weakest of the inhibitors producing greater 
t han 50 percent inhibition, requiring almost a 1 . 0 mM concentration 
to reduce the phosphatase to a half maximal rate. Ouabain, which 
is generally considered a highly specific inhibitor of Na+ , K+-
ATPase, was found to be a poor inhibitor in this system. At 0 . 33 mM 
less than 25 percent inhibition of this activity occurred. This is 
possibly due to the lack of Na+ ions in the incubation medium and 
the high K+ concentrations present (10 mM). It is also possible 
that the enzyme substrate used, 3-0- methylfluorescein phosphate, 
does not support ouabain binding to the enzyme because of a higher 
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affinity for the binding site. Acrylamide, DFP and paraoxon did not 
demonstrate any inhibitory activity in this system. Althoudh DFP, 
like other organophosphates, is considered to be a good enzyme 
inhibitor (Lehninger, 1975), it is apparent that the K+-dependent 
phosphatase activity, as examined in this study, is not adversely 
affected by any protein phosphorylation initiated by DFP. 
Comparison of the Biogenic Amine Uptake and 
K+-Dependent Phosphatase Inhibition 
by Environmental Pollutants 
Examining Table 7 closely it is evident that a correlation between 
uptake inhibition and K+-dependent phosphatase activity does not 
exist. The inorganic mercurial, Hg(N03) 2 , was the strongest inhibitor 
of the phosphatase activity but the weakest inhibitor of the uptake 
process of the chemicals capable of producing greater than 50 percent 
inhibition. Chlorpromazine had just the opposite properties, being 
the most effective uptake inhibitor but the weakest of the positive 
phosphatase inhibitors . CdCl 2 , on the other hand, was very effective 
against the phosphatase enzyme but totally ineffective in inhibiting 
either uptake process and DFP which would be expected to exert a 
strong influence on any enzymatic process has no influence, even at 
a 10-3 M concentration, on either the synaptosomal uptake or phos-
phatase properties of the membranes . Although a correlation does not 
occur between the phosphatase and uptake function of the synaptosomal 
membrane , this data indicated that several of these environmental 
pollutants were highly effective inhibitors of enzymatic processes 
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(as evidenced by the low rc50 •s for the phosphatase). This would be 
of critical importance to synaptic, as well as neuronal function, 
if the test compounds were able to permeate the plasma membranes and 
gain access to the intracellular compartments. 
It should be noted that the lack of an inhibitory influence for 
DFP was unexpected. As previously mentioned DFP is considered to be 
a good inhibitor of many enzymatic processes and Saunders (1957) 
-9 
estimated the rc50 for horse-serum cholinesterase at 10 M DFP. 
+ + Contrasting results have been reported for DFP effects on Na , K -
ATPase isolated from rat brain . Glow et al. (1972) reported that expo-
sure to sublethal doses of DFP in vivo increased the Na+, ~-ATPase 
specific activity of whole brain homogenates while decreasing 
+ + 
activities were found in Na , K -ATPase of rat cerebral cortices 
(Jovic et al., 1971). \fhatever the reasons for the qualitative 
differences in these two studies may be, the important point is that 
DFP did alter the Na+, K+-ATPase. Since K+- dependent phosphatase is 
considered to be a property of the Na+, K+-ATPase, the lack of effect 
exhibited by DFP on this enzyme was unexpected. A more extensive 
examination of the kinetics of the phosphatase would be useful in 
elucidating the extent of this ineffectiveness. 
The Significance of the Effects Environmental 
Pollutants Have on Rat Synaptosomal Membrane 
Function and Suggestions for Future Studies 
In examining the inhibition of the uptake process at various 
concentrations of toxicant it was concluded that at relatively high 
concentrations, CH3HgCl, Hg(N03) 2 and Kepone were effective inhibitors. 
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This low affinity inhibition suggests that a specific inhibition of 
the carrier-mediated transport may not exist . Rather, a non- specific 
membrane interaction may be the mechanism by which such inhibition 
occurs. The lipophilic nature of these compounds may allow for their 
insertion within the membrane, with subsequent interaction with 
membrane phospholipid or protein , leading to a disruption of the 
inherent order and functionality of the membrane. 
The information collected indicates that a correlation between 
inhibition of rat brain synaptosomal uptake and K+-dependent membrane 
phosphatase does not exist. To account for this lack of correlation 
it is possible that the rat is not a sensitive enough species for such 
studies. It is widely accepted that the chicken is the species of 
choice for studies involving neurotoxic pathology because of its 
sensitivity to chemicals inducing such effects . Although it can be 
shown that rats and other rodents are susceptible to chemically 
induced neuropathies it is generally accepted that they are less 
sensitive than other species (i . e. , chicken). Therefore , it is 
possible that a study of this nature performed with chicken synatp-
osome preparations may yield a more positive correlation . 
The results of this study also suggest that inhibition of 
synaptosomal neurotransmitter uptake is not a key factor in the 
neurotoxicity of the compounds tested. However , in vivo exposure of 
animals to these compounds followed by analysis of the uptake functions 
would be a much stronger indicator· of the existence as well as the 
significance of such an effect. It would also be of relevance to 
examine the nature of the interaction between these compounds and the 
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biogenic amines to determine whether a toxicant - amine complex formation 
occurs. Such a complex would be capable of directly influencing the 
information transfer that occurs across the synapse. Other in vitro 
--- -
studies that may provide s i gnificant information in assessing the 
potential toxicity of these compounds would include an examination 
of the actual membrane interaction that was postulated to occur . 
This could be accomplished by monitoring membrane fluidity as well 
as passive diffusional transport for changes in membrane permeability. 
It would also be of interest to determine whether these compounds 
actually permeate the membrane and accumulate within the intra-
synaptosomal compartment. If this were to occur it may ultimately 
prove to be more critical for synaptic function since these neuortoxic 
compounds would then have access to the metabolic and synthetic 
machinery of the synaptic terminal and the concentration necessary 
to disrupt this activity would likely be much less than that necessary 
for memb rane disruption. 
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SUMMARY AND CONCLUSION 
This study was undertaken t o determine if the neur otoxicity 
produced on exposure to several environmental pollutants could be 
attributed to membrane changes occuring at the synaptic processes 
of the central nervous system. An in vitro model system was used to 
determine if membrane changes were capable of being produced on 
in vitro expsoure to CH3HgCl , Hg(N03) 2 , CdCl 2 , DFP , paraoxon, 
acrylamide, and Kepone. Synaptosomal uptake of norepinephrine and 
serotonin, as well as the membrane K+- dependent phosphatase activity, 
were monitored as indicators of membrane function. 
The data presented indicates that the two mercurials , CH 3HgCl 
and Hg(N03) 2 , and the cyclodiene insecticide Kepone , were effective 
i nhibitors of both the NE and SHT carrier- mediated uptake with more 
than 50 percent inhibition occurring at concentrations greater t han 
10- 4 M. The remaining test compounds were unable to induce a signi-
ficant inhbition of this process at concentrations ranging up to 
- 3 10 M. Although CH3HgCl, Hg(N03) 2 and Kepone produced a significant 
inhibition it should be noted that the Km's for the high affinity 
NE and 5-HT transport was established to be less than 10- 6 M. The 
high rc50 values presented for these compounds as well as the 
demons tration that their effectiveness occurred over a narrow 
concentration range suggests a non- specific membrane perturbation as 
the initiating factor eliciting the inhibitory response. 
The K+- dependent phosphatase was strongly inhibited by Kepone, 
CH3HgCl, Hg(N03) 2 , and CdCl2 . The rc50 values were determined to be 
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-5 less than 10 Mwith Hg(N03) 2 having the strongest inhibitory influence. 
DFP, paraoxon and acrylamide at concentrations up to 10-3 M were 
unable to produce a significant inhibition of the phosphatase. 
Since the NE and SHT uptake is at least partially dependent on 
the energy generated from the Na+, K+ transmembrane gradient it was 
felt that the low affinity inhibition of the uptake processes might 
be a result of a direct effect on the cation gradient. Although 
the inhibition of the membrane phosphatase did occur at very low 
concentrations of the test chemicals a correlation between this 
inhibition and the monoamine uptake inhibition could not be 
demonstrated . 
The data generated from this investigation indicates that 
inhibition of the synaptosomal NE and SHT uptake on in vitro 
exposure to CH3HgCl, Hg(N03) 2 and Kepone, is not a c.ritical factor 
in the neurotoxicity produced by these compounds. The high concentra-
tions and narrow dose- response curves suggest a direct membrane 
effect as the causative factor in the inhibitory response. Although 
the uptake inhibition was not demonstrated to be a highly specific 
process, inhibition of the K+- dependent phosphatase was found to 
occur at sub- micromolar concentrations. This suggests that these 
compounds are able to influence synaptic membrane function and the 
possibility of other synaptic effects can not be ruled out. 
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